Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Rajat Bannerji, Edward A. Sausville et al.|Cancer Chemotherapy and Pharmacology|2013Cited by 94
Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid LeukemiaIvana Gojo, Douglas D. Ross, Ming Tan et al.|Clinical Cancer Research|2013Cited by 49
The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug InteractionsJasjeet Bhullar, Maria R. Baer, Suresh V. Ambudkar et al.|PLoS ONE|2013Cited by 32